Clinical trialNCT04484220CompletedInterventional

Ellipsys Vascular Access System Post Market Surveillance (PS) Study

SponsorMedtronic EndovascularEnrollment142AV FistulaFistulas ArteriovenousKidney Disease, End-StageRenal Disease, End Stage

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Haimanot Wasse, MD
Rush University Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Nephrology Associates Access Center
Riverside, California, United States
Yale University
New Haven, Connecticut, United States
Azura Vascular Care, Jacksonville
Jacksonville, Florida, United States
Coastal Vascular and Interventional, Pllc
Pensacola, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
the Vascular Care Group
Hyannis, Massachusetts, United States
Nephrology Kidney Disease Hypertension Center
Las Vegas, Nevada, United States
Staten Island Hospital
Staten Island, New York, United States
University of Pittsburg Medical Center
Pittsburgh, Pennsylvania, United States
Star Vascular Access Center
San Antonio, Texas, United States
San Antonio Kidney Disease Center
San Antonio, Texas, United States
Richmond Vascular Center
North Chesterfield, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Apr 2021
Primary completion: 31 Mar 2025
Completion: 31 Mar 2025
Last update posted: 1 Jun 2026
Registered enrollment: 142
Registry id: NCT04484220

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.